Rationale for targeting complement in COVID-19. (2020)
Attributed to:
MICA: Targeting C5aR in chronic inflammation, renal fibrosis and late graft dysfunction
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202012642
PubMed Identifier: 32559343
Publication URI: http://europepmc.org/abstract/MED/32559343
Type: Journal Article/Review
Volume: 12
Parent Publication: EMBO molecular medicine
Issue: 8
ISSN: 1757-4676